Insulin Aspart
Insulin aspart is a recombinant, rapid-acting human insulin analog designed to lower blood glucose levels. It mimics the body's natural insulin response to meals, beginning to work within 10 to 20 minutes, peaking in 1 to 3 hours, and lasting for 3 to 5 hours.
Dosage by Body Weight
Dosage must be highly individualized and determined by a healthcare provider based on metabolic needs, blood glucose monitoring, and carbohydrate intake. Typically injected subcutaneously within 5 to 10 minutes before a meal.
- Body Weight
- Below 5 kg
- Dose
- Highly individualized
- Frequency
- With meals as prescribed
- Tracking Notes
- Requires strict medical supervision, carbohydrate counting, and frequent blood glucose monitoring.
- Body Weight
- 5-7 kg
- Dose
- Highly individualized
- Frequency
- With meals as prescribed
- Tracking Notes
- Titrated carefully based on blood glucose levels and insulin sensitivity.
- Body Weight
- 8-10 kg
- Dose
- Highly individualized
- Frequency
- With meals as prescribed
- Tracking Notes
- Titrated carefully based on blood glucose levels and insulin sensitivity.
- Body Weight
- 11-15 kg
- Dose
- Highly individualized
- Frequency
- With meals as prescribed
- Tracking Notes
- Titrated carefully based on blood glucose levels and insulin sensitivity.
- Body Weight
- 16-20 kg
- Dose
- Highly individualized
- Frequency
- With meals as prescribed
- Tracking Notes
- Titrated carefully based on blood glucose levels and insulin sensitivity.
| Body Weight | Dose | Frequency | Tracking Notes |
|---|---|---|---|
| Below 5 kg | Highly individualized | With meals as prescribed | Requires strict medical supervision, carbohydrate counting, and frequent blood glucose monitoring. |
| 5-7 kg | Highly individualized | With meals as prescribed | Titrated carefully based on blood glucose levels and insulin sensitivity. |
| 8-10 kg | Highly individualized | With meals as prescribed | Titrated carefully based on blood glucose levels and insulin sensitivity. |
| 11-15 kg | Highly individualized | With meals as prescribed | Titrated carefully based on blood glucose levels and insulin sensitivity. |
| 16-20 kg | Highly individualized | With meals as prescribed | Titrated carefully based on blood glucose levels and insulin sensitivity. |
Formulation
Purpose
To improve glycemic control in adults and pediatric patients with Type 1 and Type 2 diabetes mellitus.
Generic Name
Insulin AspartBranded Drug Names
Insulin Aspart is listed as a generic drug name. Common branded medicines that may contain the same active ingredient include:
Scheduled Drug
Yes. This medicine should be supplied or used only according to applicable prescription and regulatory requirements.